Summary of Conference Call Notes Company and Industry Involved - The company discussed is **Samsung Medical**, specifically its subsidiary **Samsung Sweden** which has secured contracts for transformer manufacturing. - The industry focus is on **transformer manufacturing** and **power distribution technology**. Core Points and Arguments - Samsung Sweden has signed a framework contract with **Enexis** in the Netherlands for oil-immersed transformers, amounting to **€117 million**, approximately **¥949 million** [1] - Winning the Dutch contract indicates that Samsung's transformer manufacturing capabilities have met **global high-level certifications**, particularly due to stringent EU standards on **environmental protection**, **energy efficiency**, and **noise reduction** [1] - The company’s distribution technology is beginning to lead in overseas markets, surpassing many domestic competitors [1] Additional Important Content - The company has progressively secured contracts, starting with a **¥341 million** order for oil-immersed transformers in Brazil in 2023, followed by a **¥466 million** contract with the Greek power authority (HEDNO) in April 2024, culminating in the recent Dutch order [2] - This sequence of contracts signifies that the company's technological strength is gaining **global recognition**, moving from simpler to more complex projects [2] - Market perception is shifting positively towards **Siyuan Electric** in the mid-to-high voltage overseas market, suggesting that Samsung could become a comparable player in the international distribution system [2] - Profit forecasts for 2026 are projected at **¥2.3-2.4 billion**, with a current price-to-earnings ratio of **16x**, while Siyuan is expected to have a **45x** ratio, indicating that Samsung is significantly undervalued and warrants continued attention [2]